Literature DB >> 4092725

Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea.

I Milsom, B Andersch.   

Abstract

Intra-uterine pressure was recorded in a dysmenorrhoeic patient for 10 h before and after administration of a single dose of ibuprofen 400 mg. Blood samples were obtained at regular intervals during the recording for determination of the serum concentration of ibuprofen by reverse HPLC. The maximum serum concentration (37.4 micrograms Ml-1) was achieved after 1 h and the terminal half-life of ibuprofen was approximately 2 h. A marked reduction in intra-uterine pressure and the severity of pain was recorded 1.5 h following the administration of ibuprofen. Despite low or non-detectable serum concentrations of ibuprofen after 4 h, intra-uterine pressure never regained the level recorded before treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092725     DOI: 10.1007/BF00613459

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS.

Authors:  V R PICKLES; W J HALL; F A BEST; G N SMITH
Journal:  J Obstet Gynaecol Br Commonw       Date:  1965-04

2.  Myometrial physiology and its relation to pelvic pain.

Authors:  R A WOODBURY; R TORPIN
Journal:  J Am Med Assoc       Date:  1947-07-26

Review 3.  Pharmacokinetics of non-steroidal anti-inflammatory agents.

Authors:  G D Champion; G G Graham
Journal:  Aust N Z J Med       Date:  1978

Review 4.  The diagnostic significance of the intrauterine pressure. I.

Authors:  A Csapo
Journal:  Obstet Gynecol Surv       Date:  1970-05       Impact factor: 2.347

5.  Dysmenorrhea and its therapy: a uterine contractility study.

Authors:  W W Filler; W C Hall
Journal:  Am J Obstet Gynecol       Date:  1970-01-01       Impact factor: 8.661

6.  Pharmacokinetics of ibuprofen in man--III: Plasma protein binding.

Authors:  G F Lockwood; K S Albert; G J Szpunar; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

7.  The objective evaluation of dysmenorrhea therapy.

Authors:  R P Smith; J R Powell
Journal:  Am J Obstet Gynecol       Date:  1980-06-01       Impact factor: 8.661

8.  The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients.

Authors:  A I Csapo; M O Pulkkinen; M R Henzl
Journal:  Prostaglandins       Date:  1977-01

9.  The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients.

Authors:  M O Pulkkinen; A I Csapo
Journal:  Prostaglandins       Date:  1978-06

10.  An epidemiologic study of young women with dysmenorrhea.

Authors:  B Andersch; I Milsom
Journal:  Am J Obstet Gynecol       Date:  1982-11-15       Impact factor: 8.661

View more
  3 in total

Review 1.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

2.  Role of uterine forces in intrauterine device embedment, perforation, and expulsion.

Authors:  Norman D Goldstuck; Dirk Wildemeersch
Journal:  Int J Womens Health       Date:  2014-08-07

3.  The Prevalence, Management and Impact of Dysmenorrhea on Medical Students' Lives-A Multicenter Study.

Authors:  Romina-Marina Sima; Mihaela Sulea; Julia Caroline Radosa; Sebastian Findeklee; Bashar Haj Hamoud; Mihai Popescu; Gabriel Petre Gorecki; Anca Bobircă; Florin Bobirca; Catalin Cirstoveanu; Liana Ples
Journal:  Healthcare (Basel)       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.